Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

The objective of this study was to assess current perceptions surrounding opioid prescribing in surgical oncology to inform perioperative quality improvement initiatives. After the Society of Surgical Oncology (SSO) approval, a survey was distributed to its membership. Five sample procedures were used to assess provider perceptions and prescribing habits. Data were summarized and compared by self-reported demographics. One hundred and seventy-five participants completed the survey: 149 (85%) faculty, 24 (14%) trainees, and 2 (1%) advanced practice providers. Most participants (76%) practiced in academic programs and 21% practiced in non-US locations. Few differences were identified based on clinical role, academic rank, or practice years. Compared with non-US providers, US providers expected higher pain scores at discharge, recommended greater opioid prescriptions, and estimated more days of opioid use for almost every procedure. More non-US providers believed discharge opioids should not be distributed to patients who are opioid-free in their last 24 inpatient hours (80% vs 50%, P = .001). All providers ranked education as "very important" for reducing opioid prescriptions. Compared with their international counterparts, US surgical oncology providers expected greater opioid needs and recommended higher prescription numbers. Educating providers on multimodal opioid-sparing bundles, accelerated weaning protocols, and standardized discharge prescribing habits could have a positive impact the US opioid epidemic. © 2020 Wiley Periodicals LLC.

Citation

Heather A Lillemoe, Timothy E Newhook, Thomas A Aloia, Elizabeth G Grubbs, George J Chang, Matthew H G Katz, Jean-Nicolas Vauthey, Jeffrey E Lee, Ching-Wei D Tzeng. Perceptions of opioid use and prescribing habits in oncologic surgery: A survey of the society of surgical oncology membership. Journal of surgical oncology. 2020 Nov;122(6):1066-1073

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 32632993

View Full Text